Skip to content

Effect of early postoperative use of 590 nm pulsed laser or CO2 fractional laser on wound healing: a single-center, randomized, self-controlled trial

Effect of early postoperative use of 590 nm pulsed laser or CO2 fractional laser on wound healing: a single-center, randomized, self-controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080186
Enrollment
Unknown
Registered
2024-01-23
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scar

Interventions

Pulsed Dye Laser Group:Pulsed Fuel Laser for the first three months, Fractional CO2 for the second three months
Fractional Laser Group:Full treatment with fractional CO2

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. age 18-60 years; 2. incision length exceeding (including) 4 cm; 3. skin type III: sometimes burns, sometimes tans, common in yellow populations, or type IV: rarely burns, often tans, common in yellow populations; 4. patients undergoing dermatologic surgical procedures scheduled for one-stage suturing.

Exclusion criteria

Exclusion criteria: 1. pregnant women, women planning to become pregnant within six months, or women who are breastfeeding; 2. abnormal complete blood counts, abnormal liver or renal function; 3. history of malignancy or radiation therapy, infectious or viral skin disease, immunosuppression, prolonged systemic corticosteroid therapy, and use of any scarring treatments 4 weeks prior to the start of treatment; 4. known allergy to topical lidocaine anesthesia, and history of photosensitizing medications; 5. Wounds or ulcers at the lesion site; 6. Participation in other clinical trials; 7. Underlying medical conditions such as diabetes mellitus and hypertension.

Design outcomes

Primary

MeasureTime frame
Patient and Observer Scar Assessment Scale;

Secondary

MeasureTime frame
scar width;

Countries

China

Contacts

Public ContactJun Yang

Shanghai 9th people hospital

yj5599@Hotmail.com+86 139 0180 2159

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026